Huahui Health
Clinical trials sponsored by Huahui Health, explained in plain language.
-
New hope for advanced liver cancer patients in early trial
Disease control Not yet recruitingThis study tests a new drug called HH-009 in about 30 people with advanced liver cancer that has gotten worse after other treatments. Participants will receive one of two doses of the drug to see if it can shrink tumors or slow the cancer's growth. The goal is to find out if the …
Phase: PHASE1, PHASE2 • Sponsor: Huahui Health • Aim: Disease control
Last updated May 01, 2026 23:59 UTC
-
New drug shows promise against rare liver infection
Disease control Not yet recruitingThis study tests a new medicine called libevitug for people with chronic hepatitis D, a serious liver infection. About 160 adults will receive either a low or high dose of the drug every two weeks for 96 weeks, or wait 48 weeks before starting treatment. The goal is to see if the…
Phase: PHASE3 • Sponsor: Huahui Health • Aim: Disease control
Last updated Apr 29, 2026 15:05 UTC